Format

Send to

Choose Destination
Ann Oncol. 2016 Aug;27(8):1382-5. doi: 10.1093/annonc/mdw186. Epub 2016 Apr 29.

International cancer seminars: a focus on kidney cancer.

Author information

1
Section of Genetics, International Agency for Research on Cancer, Lyon, France.
2
Division of Cancer Epidemiology and Genetics, Department of Health and Human Service, National Cancer Institute, National Institutes of Health, Bethesda, USA.
3
Clinical and Biomedical Proteomics Group, Cancer Research UK Centre, Leeds Institute for Cancer Studies and Pathology, St James' University Hospital, Leeds, UK.
4
Department of Urology, Centre Hospitalier Universitaire d'Angers, Angers, France.
5
Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Kidney Cancer Program, Dana-Farber/Harvard Cancer Center, Boston, MA, USA.
6
Groupe de Recherche GRC-UPMC n°5, Centre de Recherche sur les Pathologies Prostatiques et Urologiques (CeRePP), Paris, France.
7
Translational Cancer Therapeutics Laboratory, UCL Cancer Institute, University College London, London, UK.
8
Duncan Cancer Center-Biostatistics, Baylor College of Medicine, Houston.
9
Department of Genetics, UNC School of Medicine, Chapel Hill, USA.
10
Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
11
University of Exeter Medical School, Exeter, UK.
12
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå Department of Biobank Research, Umeå University, Umeå, Sweden.
13
Department of Epidemiology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, USA.
14
Institute of Public Health and Preventive Medicine, Charles University, 2nd Faculty of Medicine, Prague, Czech Republic.
15
Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda.
16
Department of Medicine, University of Pennsylvania, Philadelphia, USA.
17
Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
18
Department of Pathology, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, USA.
19
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå
20
University College London Hospitals and Cancer Institute, London, UK.
21
Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, USA.
22
Section of Genetics, International Agency for Research on Cancer, Lyon, France brennanp@iarc.fr.
23
Division of Cancer Epidemiology and Genetics, Department of Health and Human Service, National Cancer Institute, National Institutes of Health, Bethesda, USA brennanp@iarc.fr.

Abstract

Recent years have seen important advances in our understanding of the etiology, biology and genetics of kidney cancer. To summarize important achievements and identify prominent research questions that remain, a workshop was organized by IARC and the US NCI. A series of 'difficult questions' were formulated, which should be given future priority in the areas of population, genomic and clinical research.

KEYWORDS:

clinical research; epidemiology; genomics; kidney cancer

Comment in

PMID:
27130845
PMCID:
PMC4959923
DOI:
10.1093/annonc/mdw186
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center